• KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
21-08-2023
Kedrion Biopharma Supports the Rare Disease Community at the 75th Annual Bleeding Disorders Conference
Kedrion supported the Plasminogen Deficiency Foundation in a roundtable for patients with Congenital Plasminogen Deficiency.
Read all
25-07-2023
Kedrion Biopharma Announces Support for the Immune Deficiency Foundation Research Grant Program for Second Consecutive Year
The IDF Research Grant Program is designed to encourage and support patient-oriented research on primary immunodeficiencies (PI),
Read all
19-07-2023
Kedrion confirms its commitment against Rabies infections in the US
Distribution agreement with Kamada for KEDRAB® extended until March 2026
Read all
Pharmacovigilange
Medical & Scientific Information
2021 Annual report